Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)
  7. Department of Pathology and Laboratory Medicine (415)
  8. Gastrointestinal Oncology Service (386)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acupuncture to reduce opioid consumption in patients with pain: Getting to the right points
    Editorial

    Deng, G.; Mao, J. J.
    Pain Medicine (2019)

    Fulltext@MSK | Save
  • The new kid on the block: Suicide gene therapy to modulate cancer immunosurveillance for children with high-risk malignant brain tumors
    Editorial

    Sait, S. F.; Karajannis, M. A.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Shared molecular targets confer resistance over short and long evolutionary timescales
    Journal Article

    Li, J.; Vázquez-García, I.; Persson, K.; González, A.; Yue, J. X.; Barré, B.; Hall, M. N.; Long, A.; Warringer, J.; Mustonen, V.; more...
    Molecular Biology and Evolution (2019)

    Fulltext@MSK | Save
  • Height and body mass index as modifiers of breast cancer risk in BRCA1/2 mutation carriers: A Mendelian randomization study
    Journal Article

    Qian, F.; Wang, S.; Mitchell, J.; McGuffog, L.; Barrowdale, D.; Leslie, G.; Oosterwijk, J. C.; Chung, W. K.; Evans, D. G.; Engel, C.; more...
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Report from the European Society of Thoracic Surgeons prospective thymic database 2017: A powerful resource for a collaborative global effort to manage thymic tumours
    Journal Article

    Ruffini, E.; Guerrera, F.; Brunelli, A.; Passani, S.; Pellicano, D.; Thomas, P.; Van Raemdonck, D.; Rocco, G.; Venuta, F.; Weder, W.; more...
    European Journal of Cardio-Thoracic Surgery (2019)

    Fulltext@MSK | Save
  • Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: A randomized, dose-ranging, double-blind, phase 2 study
    Journal Article

    Papanicolaou, G. A.; Silveira, F. P.; Langston, A. A.; Pereira, M. R.; Avery, R. K.; Uknis, M.; Wijatyk, A.; Wu, J.; Boeckh, M.; Marty, F. M.; more...
    Clinical Infectious Diseases (2019)

    Fulltext@MSK | Save
  • Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
    Journal Article

    Condorelli, R.; Mosele, F.; Verret, B.; Bachelot, T.; Bedard, P. L.; Cortes, J.; Hyman, D. M.; Juric, D.; Krop, I.; Bieche, I.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Development of tumor mutation burden as an immunotherapy biomarker: Utility for the oncology clinic
    Review

    Chan, T. A.; Yarchoan, M.; Jaffee, E.; Swanton, C.; Quezada, S. A.; Stenzinger, A.; Peters, S.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide
    Journal Article

    Yamashita, A. S.; da Costa Rosa, M.; Borodovsky, A.; Festuccia, W. T.; Chan, T.; Riggins, G. J.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Journal Article

    Chung, A. E.; Shoenbill, K.; Mitchell, S. A.; Dueck, A. C.; Schrag, D.; Bruner, D. W.; Minasian, L. M.; St. Germain, D.; O'Mara, A. M.; Baumgartner, P.; more...
    Journal of the American Medical Informatics Association (2019)

    Fulltext@MSK | Save